Project information

Vigabatrin visual field loss project

Vigabatrin is widely recognised as a very effective antiepileptic drug but can cause serious visual field defects in some patients. This project will aim to diminish these risks for all epilepsy sufferers.

Charity information: Tuberous Sclerosis Association

Tuberous Sclerosis Association logo